SHULTZ; Michael David

Patent Applications and Registrations

Patent applications and USPTO patent grants for SHULTZ; Michael David.The latest application filed is for "2-azaspiro[3.4]octane derivatives as m4 agonists".

Company Profile

2.16.21

SHULTZ; Michael David - Lexington MA
Shultz; Michael David - Cambridge MA US
Shultz; Michael David - Cambrdige MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2-azaspiro[3.4]octane Derivatives As M4 Agonists App 20210130365 - CALHOUN; Amy ; et al.	2021-05-06
2-azaspiro[3.4]octane Derivatives As M4 Agonists App 20210107889 - CALHOUN; Amy ; et al.	2021-04-15
Compounds and compositions for inhibiting the activity of SHP2 Grant 10,287,266 - Chen , et al.	2019-05-14
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Grant 10,112,931 - Caferro , et al. October 30, 2	2018-10-30
4-piperidinyl compounds for use as tankyrase inhibitors Grant RE46,942 - Chen , et al. July 10, 2	2018-07-10
Compounds And Compositions For Inhibiting The Activity Of Shp2 App 20180186770 - Chen; Zhuoliang ; et al.	2018-07-05
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20180051015 - CAFERRO; Thomas Raymond ; et al.	2018-02-22
ArylSulfonamide-based matrix metalloprotease inhibitors Grant 9,822,092 - Ehrhardt , et al. November 21, 2	2017-11-21
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Grant 9,688,672 - Caferro , et al. June 27, 2	2017-06-27
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20160318915 - CAFERRO; Thomas Raymond ; et al.	2016-11-03
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Grant 9,434,719 - Caferro , et al. September 6, 2	2016-09-06
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20160039802 - CHO; Young Shin ; et al.	2016-02-11
4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitors Grant 9,227,982 - Cheung , et al. January 5, 2	2016-01-05
2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors Grant 9,181,266 - Cheung , et al. November 10, 2	2015-11-10
4-piperidinyl compounds for use as tankyrase inhibitors Grant 9,163,003 - Chen , et al. October 20, 2	2015-10-20
4-oxo-3,5,7,8-tetrahydro-4h-pyrano[4,3-d]pyrminidinyl Compounds For Use As Tankyrase Inhibitors App 20150210709 - Cheung; Atwood Kim ; et al.	2015-07-30
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20150152093 - Caferro; Thomas Raymond ; et al.	2015-06-04
4-piperidinyl Compounds For Use As Tankyrase Inhibitors App 20150126513 - Chen; Christine Hiu-Tung ; et al.	2015-05-07
Arylsulfonamide based matrix metalloprotease inhibitors Grant 8,975,439 - Tommasi , et al. March 10, 2	2015-03-10
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Grant 8,957,068 - Caferro , et al. February 17, 2	2015-02-17
ArylSulfonamide-Based Matrix Metalloprotease Inhibitors App 20150045398 - EHRHARDT; Claus ; et al.	2015-02-12
Novel 2-piperidin-1-yl-acetamide Compounds For Use As Tankyrase Inhibitors App 20150025070 - Cheung; Atwood Kim ; et al.	2015-01-22
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20140275083 - CAFERRO; Thomas Raymond ; et al.	2014-09-18
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20140235620 - Caferro; Thomas Raymond ; et al.	2014-08-21
ArylSulfonamide Based Matrix Metalloprotease Inhibitors App 20130096105 - Tommasi; Ruben Alberto ; et al.	2013-04-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.